drugset / Trial / NCT04934904

The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block

NCT04934904 ↗

Completed 100 enrolled Zhujiang Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

In this single-center, randomized, parallel control clinical trial, patients will be randomly assigned to two groups. The treatment group receives ultrasound-guided erector spinae plane block with routine treatment of Acute Gastrointestinal Injury (AGI) for 7 days or until transferred to the general ward, while the control group only receives routine treatment of AGI. The primary outcome is the cure and remission rate of AGI.

Timeline

Start
2019-08-01
Primary completion
2021-08-23
Completion
2021-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 20 ml —